Fly Intel: Top five analyst downgrades

Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. Beyond Meat (BYND) downgraded to Underweight from Neutral at Piper Sandler with analyst Michael Lavery saying the company's current all-channel retail momentum will lag consensus expectations and foodservice consensus estimates "may be high." 2. Fisker (FSR) downgraded to Neutral from Buy at BofA with analyst John Murphy saying he views Fisker as "one of the more legitimate among the universe of start-up electric vehicle automakers," largely as a function of its relationship with contract manufacturer Magna (MGA), but he also notes that the competitive landscape is becoming "incredibly fierce." 3. Lear (LEA) downgraded to Underperform from Neutral at BofA with analyst John Murphy saying Lear has been one of the best operators among seating suppliers, but its track record of "over-earning" in its seating and e-Systems segments has corrected more recently. 4. Visteon (VC) downgraded to Underperform from Neutral at BofA with analyst John Murphy saying auto production disruption is "likely to most negatively impact the supplier link of the value chain," making that segment of his coverage where he remains relatively most cautious. 5. Genmab (GMAB) downgraded to Hold from Buy at Jefferies with analyst Peter Welford saying with the stock 40% off its March lows, he sees a lack of major near-term catalysts to sustain the momentum given that the "in-focus" epcoritamab expansion data presentation is likely not coming until mid-2022. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.